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by Oliver 1. David*
Hyperactive children were compared with a nonhyperactive control group on two
measures that reflect the presence of body lead and on a lead exposure questionnaire.
The overall hypothesis that was tested was that a relationship exists between hyper-
activity in children and a concommitant condition of increased body lead stores.
Operationally, the hypothesis was reduced to a comparison of the hyperactive group
and control group on the following measures: (1) blood lead levels; (2) post-penicilla-
mine urine lead levels; (3) scores on a lead exposure questionnaire. The designation
hyperactive or nonhyperactive was arrived at by using three different measurements:
a doctor's diagnosis; a teacher's rating scale; a parent questionnaire.
Hyperactive children had significantly higher values on all three measures than
did the controls. More than half the hyperactive children had blood lead levels in the
range considered to be raised but not toxic, and 60% of post-penicillamine urine levels
were in the "toxic" range.
It is concluded that there is an association between hyperactivity and raised lead
levels, that a large body-lead burden may exact consequencies that have hitherto been
unrealized; that the definition of what is a toxic level for blood lead needs reevaluation
and that physicians should look for raised lead levels in children with hyperactivity.
In the past two years, my colleagues and
I have been concerned with the problem of
low level lead toxicity and its possible as-
sociation with hyperactive states in children.
This problem divides naturally into two
parts: first, to establish whether in fact,
hyperactive children have higher levels of
lead then their nonhyperactive brethren
(1) and, second, if higher levels are found,
to ascertain the nature of that association;
that is, is an increased lead level a function
of a child's being hyperactive or, is that
higher lead level, in some way causally as-
sociated with the hyperactivity.
*Department of psychiatry, State University of
New York, Downstate Medical Center, Box 1195,
450 Clarkson Ave., Brooklyn, New York 11203.
We spent much of 1971-1972 evaluating
the first of the two problems and it is this
work, which will be reviewed in the present
paper.
Hyperactivity is one of many terms used
to describe a complex, multifacted syndrome.
It is characterized by the fundamental be-
havioral manifestation of a high level of
motor activity and is usually coupled with a
short attention span, low frustration toler-
ance, and hyperexcitability (2).
It is convenient to divide children with
hyperactivity into a school-age group and a
preschool one. It is very rare to see a child
with this problem before the age of three
and it is most commonly seen in the school-
age child (3). The presenting complaints of
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activity leading to dangerous situations and
inquisitiveness leading to accidental destruc-
tion (3). The school-age child is usually in
constant difficulty at home because he is
noisy, restless, and difficult to control. At
school teachers are driven to distraction
by his easy distractability, clowning and
talking out of turn. He rarely finishes his
work and as a result of all the above, is
quite commonly and- justifiably called a dis-
cipline problem (3, 4).
Studies done on hyperactive children have
revealed that they have a variety of neuro-
logical and psychological abnormalities (3,
5). The neuropsychiatric characteristics cut-
ting across this symptom complex can in-
clude abnormalities in perceptual-motor
function, intelligence and achievement tests
and tests of social maturity as well (1) as
neurological "soft" signs and EEG abnor-
malities. It is important to note that none
of these abnormalities need to be regarded
as unequivocal evidence of major damage or
abnormality of the CNS (3).
The question of causality regarding this
syndrome is quite fluid. Retrospective stud-
ies commonly show that hyperactive child-
ren have in their background a-much higher
incidence of such events as: (a) abnormali-
ties in the mother during the gestational
period; (b) difficult delivery; (c) delayed
resuscitation and/or other neonatal abnor-
malities, including low Agpar scores; (d)
postnatal difficulties, such as head trauma,
encephalitis, meningitis and other encephalo-
pathies. In those children for whom no
history of the above has occurred, the ex-
planation for the disorder may be seen to
be one or a combination of the following:
an unrecognized or unrecorded cerebral in-
sult, irregular maturation of the CNS, or
a suspected but undefined maldevelopment
of the brain (6).
Prevalence estimates of this and closely
related disorders vary, some authorities
going as high as 10-20% of our school
population (6). If we hew closely to the
prevalence of hyperactivity per se, approx-
imately 5% of children in the U.S. alone
may be suffering with this disorder.
At this point, I will review briefly a few
of the specific suspicions mentioned in
the literature prior to our work regarding
associations between brain dysfunction and
lower lead levels.
First, Stewart (4) has reported that he
was "impressed with the frequency with
which hyperactive children by history turn
out to have had an incidence of accidental
poisoning early in life, usually before the
age of three." Stewart and others have ex-
plored and continue to explore the risk of
occurrence, mortality, and morbidity of ac-
cidental poisoning in hyperactive children.
It occurred to me that a second question
can fairly be asked: namely, what is the
risk of the occurrence of the hyperactive
syndrome as a result of accidental poison-
ing-in this case lead poisoning.
Chisholm (7), in a review of chronic lead
intoxication in children, asked the question:
"What of a minor elevation of blood lead
of long standing? Would it be involved in
a cause-effect fashion with future neurologic
dysfunction?" Hardy (8) presented the hy-
pothesis that unimpressive blood lead levels
-and/or small amounts of lead, not now deem-
ed clinically important, may interfere with
enzyme systems if such poisoning occurs
during the crucial developmental period of
early childhood. When these children reach
6-7 years of age, Hardy predicts (8) many
will appear in neurological clinics with var-
ious behavior disorders, although no reports
of acute lead intoxication exist in their
medical history. Byers (9) reviewed the de-
velopment of his interest in childhood lead
poisoning and stated that clinical observa-
tion made him believe that lead plays a
deleterious role in the development of the
CNS: ". . . I originally got interested in
lead because of children who had had lead
poisoning and had been sent home from the
hospital cured, who then turned up in my
neurological clinic because they were mis-
behaving in one way or another or not learn-
ing in school . . . none of these children had
acute fulminating encephalitis. They all had
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cells, some increase in spinal fluid total
protein, gastro-intestinal symptoms and co-
proporphrin in the urine . . . when they
reached six or seven, they showed evidence
of neurologic injury" (9).
Miller and his associates (10), in a study
on mentally retarded children showed that
at blood lead levels from 20 to 40/,fg/100 ml
decreased 8-aminolevulinic acid dehydra-
tase activity occurred. Their conclusion was
that even "modest" levels of blood lead may
be associated with biochemical abnormalities
in children.
A review of the literature by Weiner
(11) on the varying psychological sequela
of lead ingestion in children concluded that
while most studies reported some degree of
mental impairment caused by lead poison-
ing, none of them showed definitely the
existence or absence of a relationship be-
tween mental impairment and asymptomatic
lead poisoning or lead poisoning less severe
than that causing encephalitis. Despite the
lack of definitive research "there is reason
to believe that undiagnosed and therefore
untreated lead poisoning, is a cause of con-
cern."
In the light of these suspicions, there-
fore, our investigation was designed to as-
certain whether hyperactive children have
larger body lead stores than nonhyperac-
tive control. The hypotheses tested were
(1) hyperactive children will have signifi-
cantly higher blood lead levels than non-
hyperactive controls and (2) hyperactive
children after challenge by a heavy metal
chelating agent will have dramatically higher
urine lead levels than controls subjected
to the same challenge. To reach this last
hypothesis we reasoned as follows. Lead in-
gestion, the primary mode of lead intake in
children, usually occurs in the age group
1-5 years, but hyperactivity is most com-
monly diagnosed in somewhat older children,
so blood lead levels in hyperactive children
might not be high enough to reflect lead
exposure happening several years earlier.
To demonstrate this earlier exposure we de-
cided to draw on bone stores of lead ac-
cumulated in the pica stage. We reasoned
that a heavy metal chelating agent, such as
penicillamine, would do this by competing
with the body tissue ligands that bind lead.
Penicillamine was chosen because of its com-
paratively low toxicity and because it could
be administered orally. The technique used
was a modification of that used by Ohlsson
(12).
I should mention a rule-of-thumb equa-
tion regarding lead excretion time: that is,
the time it takes a child to excrete lead is
roughly twice the time of the ingestion pe-
riod (13). For example, if a child of 11/2
years begins-to engage in lead pica and con-
tinues this activity until he is 41/2, one should
theoretically be able to find increased lead
stores in him from age 11/2 (when he started)
until age 101/2. Three years ingestion time
x2=6 years plus 41/2 (age when he stopped).
Methods
Hyperactivity Measures
Children were classed as hyperactive or
nonhyperactive on the basis of a doctor's
diagnosis, a teacher's rating scale (the Con-
ner's scale (14), and a parent's rating scale
(the Wherry-Weiss-Peters scale (3).
The doctor's diagnosis of hyperactivity
was based on the presence of increased mo-
tor activity, poor impulse control, short at-
tention span, hyperexcitability, and low frus-
tration tolerance. The children in the non-
hyperactive group had all been seen many
times by many different physicians and at
no time was a diagnosis of hyperactivity
entertained. All the doctors' diagnoses were
made without knowledge about lead levels.
The teacher's rating scale measures five
behavioral factors, one of which is hyper-
activity. Hyperactivity scores ranged from
1 ("not at all") to 4 ("very often"). Child-
ren were considered to be hyperactive if
they achieved a mean score of 2.5 or more
and nonhyperactive if their score was be-
low 2.5. The parent's rating scale covers six
major categories and asks the parent to
score overactivity on a scale of 0 (none)
to 4 (severe). Children were deemed hyper-
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and nonhyperactive if their score was be-
low 2.0.
If the three indices were not in accord,
the two scores that did agree were used to
designate the child hyperactive or nonhy-
peractive. If only two scores were available
the teacher's score and then the doctor's
diagnosis took precedence, in that order. If
there was only one score then that one was
used.
Exclusions
Children diagnosed as psychotic or who
had evidence of significant neurological dis-
ease were excluded.
Children with hyperactivity and an event
in their background thought to be a cause
of this condition were considered separately
from those with no such history. These
events were broken into "possible" causes
and "highly probable" causes, and these
groups were analyzed separately. Of the
191 children examined, after the above exclu-
sion processes the following groups emerged
(Table 1): (1) a hyperactive group with-
out psychosis or neurological disease and
with no evidence of an event known to be
associated with the development of hyperac-
tivity ("pure" hyperactive), (2) a hyper-
active group without psychosis or severe
neurological disease but where a "highly
probable" cause for hyperactivity existed
(e.g., a child weighing 1600 g at birth with
an ABO incompatibility occasioning a total
exchange transfusion); (3) a group similar
to group 2 but differing in that the event
thought responsible for hyperactivity was
considered not "highly probable" but "pos-
sible" (e.g., a child whose mother had been
anemic during pregnancy); (4) a group of
children with a history of lead poisoning.
All children in this group had been treated
at least 5 years previously (with one excep-
tiori). Five of the eight children in this
group were just hyperactive, three had
neurological conditions of mild-to-moderate
diffuse brain damage, one with mental re-
tardation. In addition, there was a non-
hyperactive control group judged on the
same criteria as for the hyperactive group.
General Characteristics of the Population
All the children were seen as outpatients
in one of three clinics in the Kings Country
Hospital-Downstate Medical Center complex,
which serves Brooklyn, N.Y. These three
clinics were a pediatric neurology unit, a
general pediatric clinic, and a research psy-
chopharmacology unit. This complex sees
about 145,000 children as outpatients in a
year. The breakdown of this population is
as follows (15): 61%'o male, 39%o female;
62% black, 38% white (a large proportion
of the white population is Puerto Rican);
73%o U.S. born, 12%o Puerto Rican, 15%o
other or unknown. Data on status are not
available, but of the 98%o of the population
living in Brooklyn, 53%b reside in East New
York and Bedford-Stuyvesant (areas among
the most impoverished in the city),
11% live in generally middle-class areas,
and most of the rest come from impoverished
areas similar to Bedford-Stuyvesant and
East New York.
The children we examined were typical of
this population, except that our hyperactive
population was even more predominantly
Table 1. Details of groups studied.
Age, yr Mean hyperactivity
score
Group No. Mean S.D. Range M/F Teacher Parent
"Pure" hyperactive 64 7.8 2.04 3,-11 43/12 3.2 3.2
Highly probable cause for hyper- 9 7.3 2.25 4-10 8/1 2.8 2.7
activity
Possible cause for hyperactivity 11 7.7 1.28 6-10 9/2 3.1 2.1
History of lead poisoning 8 7.3 1.73 38%9 8/0 3.5 3.4
Controls 37 7.6 2.14 3%-12 27/10 1.6 0.8
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onmale than the general clinic population, so
we chose more male controls than a simple
random selection would have provided. The
two clinics from which most of the hyper-
active subjects came contained a very small
number (4-5%o) who came from areas out-
side Brooklyn to get the benefit of a uni-
versity-based clinic. Thus, this very slight
difference in socioeconomic basis would be
in the direction of a slightly higher socio-
economic level in the hyperactive popula-
tion.
Laboratory Data
Blood Lead Levels
Two 5-ml specimens of blood were ob-
tained from each child, and a separate blood
determination was done on each specimen.
Blood lead levels were measured by the
atomic absorption spectrophotometry method
of Hessel (16). The standard deviations
for this analysis are ± 3.97 1Ag/1OO ml at a
30 Mg/i00 ml concentration and ± 5.68 jug/
100 ml at a 60 ug/100 ml concentration. The
laboratory mean for 60 specimens contain-
ing 30 ,g was 30.69 Mg/lOO ml, and the mean
on unknowns containing 60 MIg/iOO ml was
60.85.
Urine Lead Levels
The parents of almost all children (chil-
dren with a history of penicillin allergy were
excluded) were asked to give their child
250 mg penicillamine just before bedtime,
collect the first urine voided in the morn-
ing, and to bring that specimen to the
hospital on the same day. Informed parental
consent was obtained in every case by
using a form that was signed by a parent.
The consent form stated what we were doing
and the dangers involved. The method used
for the urine analysis was that used rou-
tinely by the Lead Poison Division of the
Buren"u of Laboratories in New York City.
The Bureau does not have figurcs on the
errors of measurement for urine lead de-
terminations done in their laboratory.
Results
The data were analyzed on comparing the
normal control group with each of four
groups: (1) the hyperactive group in whom
no psychosis or major neurologic disease
existed and in whom no known history of an
etiologic event thought to be associated with
hyperactivity was present, (2) the group
with a "highly probable" cause for hyper-
activity, (3) the group with a "possible"
cause for hyperactivity, (4) the group in
whom the "highly probable" cause for hyper-
activity was a documented history of overt
lead poisoning.
For each experimental group the blood
lead levels, and urine lead levels were com-
pared to those of the control groups (Table
2). The "pure" hyperactives are significantly
different from the control group on these
(2) measures.
Table 2. Blood lead and post-penicillamine urine lead levels in four groups of hyper-
active children compared with nonhyperactive controls.
Blood lead Post-penicallimine
urine lead
No. Mean S.D., P2 No. Mean S.D., P '
Group tested ,,g/100 ml tested ,ugA
"Pure" hyperactive 54 26.23±8.41 <0.01 50 146±144 <0.025
History of lead 8 41.06±12.18 <0.001 4 32,5±167 <0.001
poisoning
Highly probable cause 9 22.89±6.60 N.S. 5 46±32 N.S.
of hyperactivity
Possible cause for 8 29.94±7.35 <0.01 9 189±155 <0.01
hyperactivity
Controls 37 22.16±9.59 - 24 77±92
2 Students t test (one tail).
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active group was-26.23 ug/100 ml, and that
of the control group was 22.16 ug/100 ml
(P) <0.01). The mean values for the post-
penicillamine urine lead level are 77 Mg/l.
in the control group and 146 jg/l. in the
hyperactive group (0.25 <P <0.01).
The results indicate that the "pure" hyper-
active subjects had higher blood lead levels,
and urine lead levels than the control sub-
jects.
The group of experimental-subjects with
a "possible" cause for their hyperactivity
showed a similar pattern of significantly ele-
vated blood and urine lead levels (Table
2) (both P values <0.01). The hyperac-
tive subjects had a mean blood lead level of
29.94 ,Mg/i00 ml (controls 22.16 Mg/i00 ml);
mean urine lead levels of 189 jug/l. (control
77 Mg/i.).
In contrast to these two groups were the
results for the hyperactive subjects with a
highly probable cause of their hyperactiv-
ity (Table 2). On these two measure they
showed no significant difference from the
controls. The mean blood and urine lead
leJbls were 22.89 ug/100 ml and 46 Mg/l.,
respectively. The comparable scores for the
controls were 22.16 Mg/100 ml and 77 pg/l.
This rather clearly indicates that lead level
is not ubiquitously related to hyperactivity.
Finally, the group with a history of lead
poisoning was compared to the normal con-
trol group (Table 2). The means for this
group were 41.06 ,g/100 ml mean blood lead
level, and 325 pgll. mean urine lead level.
The difference between the means of this
group and that of the control group easily
reached the 0.001 level of significance on
both measures.
The range and frequency distribution of
these findings were also analyzed in the light
of what are now considered to be normal,
marginal, and toxic levels. Frequency analy-
ses of these measures for each group of
hyperactive subjects are presented in Table
3. For the blood and urine measures, x2 anal-
yses were performed comparing the pure
hyperactive group and the control group in
terms of the proportion of subjects having
normal or elevated values. (A normal blood
lead value is here defined at 24.5 pg/100 ml
or less; a normal urine lead level was de-
fined as 80 Mg/l. or less.)
An examination of Table 3 shows that for
the normal control subjects 75% had "nor-
mal" blood lead levels and 27% were in the
elevated range. In the pure hyperactive
group, 52% showed elevated blood lead val-
ues and 48% were within normal range. A
chi-square analysis with one degree of free-
dom indicates that the probability of this
frequency happening by chance is 0.02 >P
>0.01. Post-penicillamine urine lead scores
for these two groups show that 62% of
hyperactive children had elevated levels
while only 21% of the controls had elevated
levels. Of the normal subjects 79%o had
urine levels within normal limits, while this
was true for only 38% of the "pure" hyper-
active subjects. A chi-square analysis indi-
cates that the probability of this occurring
by chance is P >0.001.
The frequency analysis of blood lead levels
and urine lead levels for the "possible
cause" group was as follows: 62.5%o had
elevated blood lead scores and 78% had
elevated urine lead scores (Table 3).
The last group compared to the normal
controls is the hyperactive group whose
("highly probable" reason for hyperactivity
is a documented past history of overt lead
poisoning. The frequency of elevated blood
and urine scores in this group is 100%o.
Discussion
Lin-Fu (17) has commented on some of
the erroneous concepts regarding "normal"
blood lead levels. One of the points she
makes is that most papers equate the lowest
blood lead level diagnostic of clinically mani-
fest lead poisoning with the upper limits of
normal. A level not associated with overt
clinical evidence of toxicity surely does not
have to be normal. "Symptoms from low
level lead intake may for example be over-
looked because no one knows what to look
for. Thus, children are considered asymp-
tomatic because classic symptoms and
signs of lead poisoning are absent." She
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varying blood lead levels from 80 jug/100
ml to 20 jug/100 ml as upper limits of nor-
mal. It is, however, fair to say that over the
years the "mainstream" concept of what the
upper limit of normal is has been dropping.
At present most authorities agree that a
blood lead value below 24.5 jug/100 ml is
normal and a value above 55 Jug/100 ml is
abnormal (although not necessarily requir-
ing treatment). Our findings suggest that
the arguments for considering any lead ele-
vation above 24.5 jug/100 ml as dangerous
should receive serious attention.
A massive single dose of lead can result
in death or severe brain damage, and in
many cases a large dose of lead ingested
over a period of time can also lead to very
severe brain damage. It seems reasonable
to infer, therefore, that raised levels of lead
(not necessarily in the toxic range) present
over a long period could be responsible for
the minimal brain damage that may be pres-
ent in the hyperactive syndrome.
Our finding of raised post-pencillamine
lead levels in urine in combination with the
high blood lead values indicate that many
hyperactive children have had increased
body lead stores for a long time. It is con-
ceivable that one consequence of this con-
stant minimal poisonous assault is hyper-
activity. If we hold lead exposure responsible
for some cases of hyperactivity (an assump-
tion only), we might predict the following:
(1) there would be little difference in lead
values between the normal control group
and the "highly probable cause" group (i.e.,
the group with a likely cause for hyperac-
tivity other than lead); (2) the "pure" hy-
peractive group and the "possible" group
would both show raised lead levels. (The
"possible" group differs from the "highly
probable" group in the crucial distinction of
a convincing other cause for hyperactivity
being absent.) These predictions are sup-
ported by the results.
All eight hyperactive children who also
had a history of lead poisoning had elevated
blood and urine lead levels at the time of
the study. All but one had been treated
with chelating agents at least 5 years pre-
viously. This finding indicates that the treat-
ment of these lead-poisoned children may
not have been extensive enough and/or that
follow-up procedures had been unsuccessful.
It may also mean that hyperactivity hereto-
fore thought to be a relatively common con-
sequence of lead poisoning is not necessarily
a consequence at all, but a condition that is
dependent on continuing elevations (non-
lethal) of body lead.
Might the lead levels recorded be a con-
sequence of the child's hyperactivity rather
than a hyperactivity cause? This interpreta-
tion is not supported by the finding that
the "highly probable cause" hyperactive
group do not show increased blood or urine
lead levels. There are, however, too few
children in that group to arrive at a definite
conclusion.
Hyperactivity is a symptomatic state, not
a disease. Being able to segregate a group
of such children in whom the etiology is
known (e.g., due to lead) would be extremely
helpful and might be useful in further
research of the hyperactive child syndrome.
Despite the lack of proof of a causal relation
between the hyperactivity and lead, blood
lead levels and post-penicillamine urine lead
levels should be routine investigations in
cases of hyperactivity.
Before ending this discussion, a word must
be said concerning the social and environ-
mental implications of this work. It will be
remembered that estimates concerning the
prevalence of hyperactivity range from 5%
of our child population on up. If we estimate
the child population to be roughly 20-25%o
of the total, we find that 5%o of this is
approximately 2,000,000 people. It is con-
ceivable that via the findings contained
herein, the possibility of a direct ameliora-
tion of that condition is possible in fully,
1,000,000 children. What this might mean in
terms of immediate treatment and the avoid-
ance of complicating social and personal
sequelae and in public health terms is stag-
gering.
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